Tan Qing, Liu Qing-Jun, Fan Wen-Hui, Du Xiao-Yan, Wu Lin, Gong Hong-Min, Wei Jing, Zhao Rui, Lei Ming, Zhao Li-Bo
Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China.
Front Neurol. 2021 Sep 8;12:673703. doi: 10.3389/fneur.2021.673703. eCollection 2021.
Thousands of designated COVID-19 hospitals have been set up in China to fight the ongoing COVID-19 pandemic. Anecdotal reports indicate a falling rate of acute stroke diagnoses in these hospitals during the COVID-19 period. We conducted an exploratory single-center analysis to estimate the change in acute stroke presentation at the designated COVID-19 hospitals. This retrospective observational study included all patients admitted to Yongchuan Hospital Affiliated to Chongqing Medical University with acute stroke between January 24 and March 10, 2020. Patient demographics, characteristics of the stroke, treatment details, and clinical outcomes were compared with those of patients admitted in the corresponding period in the year before (2019, "the pre-COVID-19 period"). Subgroup analysis was performed in the ischemic and hemorrhagic stroke groups. A total of 110 patients presented with acute stroke symptoms during the COVID-19 pandemic, compared with 173 patients in the pre-COVID-19 period. A higher proportion of stroke patients presented to the hospital emergency medical services during the pandemic (48.2 vs. 31.8%, = 0.006). There was a lower proportion of ischemic stroke patients (50.9 vs. 65.3%, = 0.016) than in the preceding year. There were significantly fewer patients with 90-day modified Rankin Scale score ≥3 in the COVID-19 period compared with the pre-COVID-19 period (17.3 vs. 30.6%, = 0.012). Among patients with ischemic stroke, the mean time from patient arrival to vessel puncture for emergency endovascular therapy in the COVID-19 period was shorter than that in the pre-COVID-19 period (109.18 ± 71.39 vs. 270.50 ± 161.51 min, = 0.002). Among patients with hemorrhagic stroke, the rate of emergency surgical operation in the COVID-19 period was higher than that in the pre-COVID-19 period (48.1 vs. 30.0%, = 0.047). The mean time from patient arrival to emergency surgical operation (15.31 ± 22.89 vs. 51.72 ± 40.47 min, = 0.002) was shorter in the COVID-19 period than in the pre-COVID-19 period. Although fewer acute stroke patients sought medical care in this designated COVID-19 hospital during the COVID-19 pandemic, this type of hospital was more efficient for timely treatment of acute stroke. Recognizing how acute strokes presented in designated COVID-19 hospitals will contribute to appropriate adjustments in strategy for dealing with acute stroke during COVID-19 and future pandemics.
中国已设立数千家新冠肺炎定点医院来抗击当前的新冠肺炎疫情。轶事报道表明,在新冠肺炎疫情期间,这些医院急性中风的诊断率有所下降。我们进行了一项探索性单中心分析,以评估新冠肺炎定点医院急性中风就诊情况的变化。这项回顾性观察研究纳入了2020年1月24日至3月10日期间入住重庆医科大学附属永川医院的所有急性中风患者。将患者的人口统计学特征、中风特点、治疗细节及临床结局与前一年(2019年,“新冠肺炎疫情前时期”)同期入院的患者进行比较。对缺血性和出血性中风组进行了亚组分析。在新冠肺炎疫情期间,共有110例患者出现急性中风症状,而在新冠肺炎疫情前时期为173例。疫情期间,中风患者通过医院急诊医疗服务就诊的比例更高(48.2%对31.8%,P = 0.006)。与上一年相比,缺血性中风患者的比例更低(50.9%对65.3%,P = 0.016)。与新冠肺炎疫情前时期相比,新冠肺炎疫情期间90天改良Rankin量表评分≥3分的患者明显更少(17.3%对30.6%,P = 0.012)。在缺血性中风患者中,新冠肺炎疫情期间从患者到达至进行急诊血管内治疗的血管穿刺平均时间比新冠肺炎疫情前时期更短(109.18±71.39分钟对270.50±161.51分钟,P = 0.002)。在出血性中风患者中,新冠肺炎疫情期间急诊手术率高于新冠肺炎疫情前时期(48.1%对30.0%,P = 0.047)。新冠肺炎疫情期间从患者到达至急诊手术的平均时间(15.31±22.89分钟对51.72±40.47分钟,P = 0.002)比新冠肺炎疫情前时期更短。尽管在新冠肺炎疫情期间,这家新冠肺炎定点医院寻求医疗救治的急性中风患者较少,但这类医院在急性中风的及时治疗方面效率更高。了解新冠肺炎定点医院中急性中风的就诊情况将有助于在新冠肺炎疫情及未来大流行期间对急性中风应对策略进行适当调整。